SCLEROSIS, MULTIPLE

Clinical trials for SCLEROSIS, MULTIPLE explained in plain language.

Never miss a new study

Get alerted when new SCLEROSIS, MULTIPLE trials appear

Sign up with your email to follow new studies for SCLEROSIS, MULTIPLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Sleep hormone tested to halt debilitating MS progression

Disease control Terminated

This study aimed to see if adding the hormone melatonin to the standard drug ocrelizumab could safely help slow down disability in people with a fast-progressing form of multiple sclerosis (MS). It involved 25 adults with primary progressive MS who were already stable on ocrelizu…

Matched conditions: SCLEROSIS, MULTIPLE

Phase: PHASE1, PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

SCLEROSIS, MULTIPLE

Get alerted when new SCLEROSIS, MULTIPLE trials appear

Sleep hormone tested to halt debilitating MS progression